Hikal: Founder ends Chairman term, director resigns, new divisional CEO appointed
HIKAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Jai Hiremath, founder, ended his term as Executive Chairman on Oct 1, 2026 after nearly four decades. He takes an honorary Chairman Emeritus role for five years but is no longer a Director or KMP. Non-Executive Director Mrs. Sugandha Hiremath (on board since 1992) resigned effective Sept 30, 2026 for personal reasons, also exiting Audit, Stakeholders' Relationship and CSR Committees. Mr. Anish Swadi, internal since 2021, appointed CEO of Animal Health and Specialty Ingredients.
Significant leadership change at Hikal. Founder exits executive role, family director resigns, new divisional CEO appointed. Watch succession closely.